PALO ALTO, Calif., Sept. 23, 2019 /PRNewswire/ -- Varian (NYSE:
VAR) today announced the United States Trade Representative (USTR)
has granted exclusion of components sourced
from China for linear accelerators manufactured in the
U.S from Section 301 tariffs. The exemption became effective on
September 20, 2019.
"We are thankful for the USTR and U.S. government's continued
recognition of the positive impact of Varian treatment technology
in the fight against cancer by granting a tariff exclusion to these
components," said Dow Wilson, president and chief executive
officer, Varian. "The supply of components without disruption plays
an important role in our system manufacturing process so we can
continue delivering cancer fighting technology and honor our
commitment to creating a world without fear of cancer."
Varian is in its quiet period but will evaluate if further
comments are necessary after completing its assessment of the
impact of this exclusion. The company's fiscal year 2019
earnings conference call is scheduled for Wednesday, October 23, 2019 at 1:30pm Pacific Time.
About Varian
At Varian, we envision a world without
fear of cancer. For more than 70 years, we have developed, built
and delivered innovative cancer care technologies and solutions for
our clinical partners around the globe to help them treat millions
of patients each year. With an Intelligent Cancer Care approach, we
are harnessing advanced technologies like artificial intelligence,
machine learning and data analytics to enhance cancer treatment and
expand access to care. Our 9,200 employees across 70 countries keep
the patient and our clinical partners at the center of our thinking
as we power new victories in cancer care. Because, for cancer
patients everywhere, their fight is our fight. For more
information, visit http://www.varian.com and follow
@VarianMedSys on Twitter.
Press Contact
Mark
Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-us-tariff-exclusion-request-granted-for-radiotherapy-system-components-300922725.html
SOURCE Varian